Whether you have personal experience with cosmetic surgery or not, this corner of the economy is probably larger than you imagine. Grandview Research recently valued the global cosmetic surgery and ...

InMode shares experienced a significant drop of 20% in one trading day, but the decline is seen as excessively harsh. InMode's unique product line bridges the gap between surgical procedures and ...

InMode's Q4 revenue dropped YOY; management optimistic about new platforms despite industry challenges. High dependence on U.S. revenue from minimally invasive procedures; facing increasing ...

Forbes contributors publish independent expert analyses and insights. Meggen Harris writes about entrepreneurs in beauty and wellness. Now that I am officially divorced, I decided to embark on a few ...

InMode said Q4 came in “slightly better than expected” but full-year revenue fell about 6% to $370.5M, and management expects 2026 to be a stabilization year rather than a return to growth despite ...

InMode (NASDAQ:INMD) is a promising aesthetic medical product player. Its proprietary radio frequency platform is the focal point of its innovative product offering. However, the company’s financial ...

Analysts' price targets for this stock suggest it could soon put up some big gains. Individual investors who want help picking stocks have more than a few options to choose from, including the ...

InMode specializes in making equipment for less-invasive aesthetic procedures. Medtronic is one of the largest equipment makers in the world. Medtronic offers an above-average dividend. Medical stocks ...

InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation ...